JCM
CLB icon

Jacobi Capital Management’s Core Laboratories CLB Stock Holding History

Jacobi Capital Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1
Closed – – 986
2018
Q2 		$0 Sell
1
-106
-99% -$12.9K ﹤0.01% 1014
2018
Q1 		$11K Hold
107
– – ﹤0.01% 668
2017
Q4 		$13K Buy
107
+1
+0.9% +$100 ﹤0.01% 623
2017
Q3 		$10K Buy
106
+1
+1% +$97 ﹤0.01% 637
2017
Q2 		$11K Hold
105
– – ﹤0.01% 548
2017
Q1 		$12K Hold
105
– – 0.01% 434
2016
Q4 		$13K Buy
105
+1
+1% +$111 0.01% 394
2016
Q3 		$12K Hold
104
– – 0.01% 443
2016
Q2 		$12K Buy
+104
New +$12.6K 0.01% 424

Other funds holding CLB

WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Royal London Asset Management
Royal London Asset Management United Kingdom $54.3B AUM 39.21% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jacobi Capital Management's CLB Position: Q3 2018 in Review

Jacobi Capital Management sold out of Core Laboratories (CLB) in Q3 2018, closing a stake of 1 share.

Jacobi Capital Management first reported a position in CLB in Q2 2016 and held it in 9 quarters. The position peaked at $13K in Q4 2017. 359 funds tracked by Wall St. Rank hold CLB as of Q3 2018.

  • Jacobi Capital Management reported no remaining Core Laboratories position as of Q3 2018 after selling out during the quarter.
  • Jacobi Capital Management sold 1 Core Laboratories share in Q3 2018.
  • Jacobi Capital Management first reported a position in Core Laboratories in Q2 2016 and held it in 9 quarters.
  • Jacobi Capital Management's Core Laboratories position peaked at $13K in Q4 2017.
  • 359 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2018.

Based on Jacobi Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.